China is a unique actor in the field of Science, Technology and innovation. Not only it has declared its goal to become a technology superpower by 2049 but it is also pouring massive financial resources into achieving it. While the Western European countries have become more aware of the risks associated with the scientific collaboration with China have introduced risk mitigation measures, Central European researchers downplay the attractiveness of the research in Central Europe for China and lack awareness of STI goals and priorities.
This Month’s Guest:
- Ivana Karásková, Founder and Leader of CHOICE & China Research Fellow at the Association for International Affairs (AMO), MERICS European China Policy Fellow